|
at 07:05 |
|
|
GRAIL, LLC., a healthcare company whose mission is to detect cancer early when it can be cured, today will host a virtual Capital Markets Day. Members from GRAIL's management team will outline growth drivers for Galleri®, a clinically validated,...
|
|
at 07:05 |
|
|
Quince Therapeutics, Inc. , a late-stage biotechnology company developing an innovative drug delivery technology designed to leverage a patient's own biology to deliver rare disease therapeutics, today provided an update on the company's development...
|
|
at 07:05 |
|
|
Harrow , a leading U.S. eyecare pharmaceutical company, is pleased to announce the appointment of Greg DiPasquale as Senior Vice President, Head of Commercial, effective immediately. DiPasquale will oversee sales, marketing, and sales operations for...
|
|
at 07:05 |
|
|
Incyte Corporation (the "Company") today announced that its Board of Directors approved a share repurchase authorization of $2.0 billion. The Company has commenced a modified "Dutch Auction" tender offer to repurchase shares of its common stock for...
|
|
at 07:05 |
|
|
Boundless Bio , a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced financial results for the...
|
|
at 07:05 |
|
|
Ajax Therapeutics, Inc., a biopharmaceutical company developing next generation JAK inhibitors for patients with myeloproliferative neoplasms (MPNs), today announced the closing of an oversubscribed $95 million Series C financing. Proceeds from the...
|
|
|
